HIMS
Hims & Hers Health·NYSE
--
--(--)
--
--(--)
4.71 / 10
Netural
Analyst consensus is neutral (71% neutral, 14% buy, 7% strong buy, 7% strong sell). Fund‑flow score is 7.88/10, good, with overall inflow ratio ~0.49 but negative trend except small‑cap inflow positive. Sentiment remains mixed, urging careful monitoring.
Fund Flow Rating
Analyst RatingBuy
Wall Street Opinions
Buy
Strong Buy
7%
Buy
14%
Hold
0%
Sell
0%
Strong Sell
7%
Allen LutzNeutral
Date2026-03-10
InstitutionB of A Securities
Times predicted4
Historical Win Rate50.0%
Craig HettenbachNeutral
Daniel GrosslightNeutral
David LarsenNeutral
George HillNeutral
Is money flowing into or out of HIMS?
- HIMS holds a Bearish analyst rating, with 14% of experts assigning a Buy grade. Factoring in net Outflows from order flow data, the comprehensive Sentiment Score stands at 4.71/10 (Netural).
